Health Services · Medical/Nursing Services · NSE: METROPOLIS · data 2026-10-09

Metropolis Healthcare Ltd.

Health check: Strong (6.7/10 on quality, valuation vs sector, growth and momentum).

Open full analysis — chart, results, balance sheet, red flags →

Key figures

Price

₹529.25

Market cap

₹10,899 cr

P/E

54.5

P/B

—

ROE

13.4%

ROCE

16.3%

Debt / equity

0.15

Dividend yield

0.38%

1-year return

4.9%

52-week high

₹609.05

52-week low

₹412.25

Operating margin

16.8%

Growth

Revenue (last 12 months)	₹1,710 cr
Net profit (last 12 months)	₹202 cr
Sales growth, 3 years (yearly)	12.8%
Profit growth, 3 years (yearly)	10.0%

Similar companies

Dr. Agarwal's Health Care Ltd. (AGARWALEYE) · Vijaya Diagnostic Centre Ltd. (VIJAYA) · Thyrocare Technologies Ltd (THYROCARE) · Nephrocare Health Services Limited (NEPHROPLUS) · Jeena Sikho Lifecare Limited (JSLL)

The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.

Open METROPOLIS in NSE Scanner →